---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001334"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:28:40.592826+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "medium"
source: SEC EDGAR
---

# Artelo raises ~$9.5M private placement to buy Solana; gets UK MHRA nod for Phase 1 trial

## Summary
- Gross proceeds ~$9.475M from 593,252 shares at $10.20 plus prefunded warrants; also issues Market Priced ($10.20) and $50.00 warrants.
- Net proceeds from shares will be used to purchase SOL; warrant proceeds for working capital and additional SOL.
- UK MHRA provided favorable guidance for first-in-human Phase 1 trial of ART12.11 (CBD:TMP cocrystal) for anxiety/depression.
- Offering expected to close Aug 5, 2025; registration statement to be filed within 15 days of closing.

## SEC filing metadata
- accession: 0001640334-25-001334
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: medium
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001334/0001640334-25-001334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001334/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001334
- JSON: https://secwatch.observer/filing/0001640334-25-001334.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001334.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.